Author/Creator: Yancey, Steven W. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Yancey, Steven W.

1. A Phase 1 study of the long‐acting anti‐IL‐5 monoclonal antibody GSK3511294 in patients with asthma. Issue 2 (24th August 2021)

Authors:: Singh, Dave; Fuhr, Rainard; Bird, Nicholas P.; Mole, Sarah; Hardes, Kelly; Man, Yau Lun; Cahn, Anthony; Yancey, Steven W.; Pouliquen, Isabelle J.
Journal:: British journal of clinical pharmacology
Issue:: Volume 88:Issue 2(2022)
Page Start:: 702
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. Baseline blood eosinophil count as a predictor of treatment response to the licensed dose of mepolizumab in severe eosinophilic asthma. (November 2019)

Authors:: Albers, Frank C.; Licskai, Christopher; Chanez, Pascal; Bratton, Daniel J.; Bradford, Eric S.; Yancey, Steven W.; Kwon, Namhee; Quirce, Santiago
Journal:: Respiratory medicine
Issue:: Volume 159(2019)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of ≥150–300 cells/μL. (May 2019)

Authors:: Yancey, Steven W.; Bradford, Eric S.; Keene, Oliver N.
Journal:: Respiratory medicine
Issue:: Volume 151(2019)
Page Start:: 139
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Economic analysis of the phase III MENSA study evaluating mepolizumab for severe asthma with eosinophilic phenotype. (4th March 2017)

Authors:: Basu, Anirban; Dalal, Anand; Canonica, Giorgio Walter; Forshag, Mark; Yancey, Steven W.; Nagar, Saurabh; Bell, Christopher F.
Journal:: Expert review of pharmacoeconomics & outcomes research
Issue:: Volume 17:Number 2(2017)
Page Start:: 121
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Effect of mepolizumab in severe eosinophilic asthma according to omalizumab eligibility. (July 2019)

Authors:: Humbert, Marc; Albers, Frank C.; Bratton, Daniel J.; Yancey, Steven W.; Liu, Mark C.; Hozawa, Soichiro; Llanos, Jean-Pierre; Kwon, Namhee
Journal:: Respiratory medicine
Issue:: Volume 154(2019)
Page Start:: 69
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Evaluation of sputum eosinophil count as a predictor of treatment response to mepolizumab. Issue 2 (3rd May 2022)

Authors:: Pavord, Ian D.; Buhl, Roland; Kraft, Monica; Prazma, Charlene M.; Price, Robert G.; Howarth, Peter H.; Yancey, Steven W.
Journal:: ERJ open research
Issue:: Volume 8:Issue 2(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Evaluation of the psychometric properties of the St George's Respiratory Questionnaire in patients with severe asthma. (July 2017)

Authors:: Nelsen, Linda M.; Vernon, Margaret; Ortega, Hector; Cockle, Sarah M.; Yancey, Steven W.; Brusselle, Guy; Albers, Frank C.; Jones, Paul W.
Journal:: Respiratory medicine
Issue:: Volume 128(2017)
Page Start:: 42
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

8. From DREAM to REALITI‐A and beyond: Mepolizumab for the treatment of eosinophil‐driven diseases. Issue 3 (16th September 2021)

Authors:: Pavord, Ian D.; Bel, Elisabeth H.; Bourdin, Arnaud; Chan, Robert; Han, Joseph K.; Keene, Oliver N.; Liu, Mark C.; Martin, Neil; Papi, Alberto; Roufosse, Florence; Steinfeld, Jonathan; Wechsler, Michael E.; Yancey, Steven W.
Journal:: Allergy
Issue:: Volume 77:Issue 3(2022)
Page Start:: 778
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

9. Health outcomes after stopping long-term mepolizumab in severe eosinophilic asthma: COMET. Issue 1 (10th January 2022)

Authors:: Liu, Mark C.; Bel, Elisabeth H.; Kornmann, Oliver; Moore, Wendy C.; Kaneko, Norihiro; Smith, Steven G.; Martin, Neil; Price, Robert G.; Yancey, Steven W.; Humbert, Marc
Journal:: ERJ open research
Issue:: Volume 8:Issue 1(2022)
Page Start:
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

10. No genetic associations with mepolizumab efficacy in COPD with peripheral blood eosinophilia. (August 2019)

Authors:: Condreay, Lynn D.; Gao, Chuan; Bradford, Eric; Yancey, Steven W.; Ghosh, Soumitra
Journal:: Respiratory medicine
Issue:: Volume 155(2019)
Page Start:: 26
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗